Resources Top 5: Chariot races to the front in new African lithium hot spot
Suffering from news overwhelm? Here are three tips to protect your peace
Lunch Wrap: ASX shrugs off US trade concerns; Nvidia and Bitcoin surge
Health Check: For ASX biotechs, the business of America remains business
The ASX explorers preparing to drill baby, drill in the land of opportunity
Break it Down: Orthocell books first sales revenue in US for Remplir
Five ways to make interest rates work harder for you
Trump tariff threat sends US copper price soaring – how will it impact miners?
Why Brazil’s rare earth deposits could catch major attention
DY6 Metals carves itself a slice of Cameroon’s growing rutile pie
Contributors
Our Resident Experts
Mining
The ASX explorers preparing to drill baby, drill in the land of opportunity
Trump tariff threat sends US copper price soaring – how will it impact miners?
Why Brazil’s rare earth deposits could catch major attention
DY6 Metals carves itself a slice of Cameroon’s growing rutile pie
Resources Top 5: Smackover sale sees Pantera Lithium skyrocket
Featured in Mining
Tech
Amazon on verge of using more robots than people
Cloudflare blocks ChatGPT and other AI bots from ‘ripping off’ content
‘Vital national security asset’: Treat data centres like oil rigs
Road safety tech ‘missing’ from Aussie cars
ASX Tech June Winners: Defence tech stocks dominate record-breaking month
Featured in Tech
Health & Biotech
Health Check: For ASX biotechs, the business of America remains business
Health Check: POTUS puts drug tariffs back on agenda… another case of TACO?
Health Kick Podcast: Neurizon’s ALS push and trial plans
ASX biotechs join global race for cell therapy breakthroughs
EchoSolv enters Mayo’s test zone as it chases FDA approval
Featured in Health & Biotech
Experts
The winners and losers from new superannuation rules
Are ETFs behind Commonwealth Bank’s record run?
ASX Trader: Why the next market crash might already be on the calendar
AI is reshaping investment portfolios
Criterion: Buy, hold or sell CBA? Investors face their NFY resolution
Stock Tips: An iron giant and a biotech behemoth make their presence felt
Precision Points: The cycle abides
